|
CYCN Cyclerion Therapeutics Inc 1755237 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,177,000.00 |
| Balance Sheet |
|
Current Assets
|
$3,089,000.00 |
|
Assets
|
$8,505,000.00 |
|
Current Liabilities
|
$1,714,000.00 |
|
Equity
|
$6,791,000.00 |
|
Shares Out
|
4241260.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,176,000.00 |
|
Investing Cash Flow
|
$-66,000.00 |
| Market Analysis |
Market Cap
|
$14,844,410.00 |
|
Price
|
$3.40 |
|
BVPS
|
1.60 |
|
PB
|
2.19 |
|
EPS
|
-0.76 |
|
FCF
|
$-1,242,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:44 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:44 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CYCN documents filed with the SEC.
CYCN Filings
Clear
